Long-Term Outcomes in Critically Ill Septic Patients Who Survived Cardiopulmonary Resuscitation

Critical Care Medicine
Pei-Wen ChaoChia-Jen Shih

Abstract

To evaluate the long-term survival rate of critically ill sepsis survivors following cardiopulmonary resuscitation on a national scale. Retrospective and observational cohort study. Data were extracted from Taiwan's National Health Insurance Research Database. A total of 272,897 ICU patients with sepsis were identified during 2000-2010. Patients who survived to hospital discharge were enrolled. Post-discharge survival outcomes of ICU sepsis survivors who received cardiopulmonary resuscitation were compared with those of patients who did not experience cardiopulmonary arrest using propensity score matching with a 1:1 ratio. None. Only 7% (n = 3,207) of sepsis patients who received cardiopulmonary resuscitation survived to discharge. The overall 1-, 2-, and 5-year postdischarge survival rates following cardiopulmonary resuscitation were 28%, 23%, and 14%, respectively. Compared with sepsis survivors without cardiopulmonary arrest, sepsis survivors who received cardiopulmonary resuscitation had a greater risk of all-cause mortality after discharge (hazard ratio, 1.38; 95% CI, 1.34-1.46). This difference in mortality risk diminished after 2 years (hazard ratio, 1.11; 95% CI, 0.96-1.28). Multivariable analysis showed that independen...Continue Reading

References

Dec 28, 1999·JAMA : the Journal of the American Medical Association·S J GoodlinR S Phillips
May 17, 2002·The New England Journal of Medicine·Riyad B Abu-LabanVictor M Wood
Apr 20, 2004·Critical Care Medicine·R Phillip DellingerUNKNOWN Surviving Sepsis Campaign Management Guidelines Committee
Mar 30, 2005·Annals of Emergency Medicine·Andrew WorsterKevin Eva
Mar 31, 2009·Journal of Critical Care·Rubin I CohenAlan Silver
Jul 3, 2009·The New England Journal of Medicine·William J EhlenbachRenee D Stapleton
Mar 4, 2010·JAMA : the Journal of the American Medical Association·Hannah WunschWalter T Linde-Zwirble
Apr 24, 2010·American Journal of Respiratory and Critical Care Medicine·Jianmin TianUNKNOWN American Heart Association National Registry for Cardiopulmonary Resuscitation Investigators
Aug 17, 2011·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Demetrios J KutsogiannisPeter G Brindley
Jan 10, 2012·Journal of Critical Care·Hayley B GershengornHannah Wunsch
Nov 16, 2012·The New England Journal of Medicine·Saket GirotraUNKNOWN American Heart Association Get with the Guidelines–Resuscitation Investigators
Jan 19, 2013·Critical Care Medicine·Colin R Cooke, Theodore J Iwashyna
Nov 10, 2013·Critical Care Medicine·Elizabeth K StevensonAllan J Walkey
Feb 27, 2014·Intensive Care Medicine·Ali Al-AlwanRenee D Stapleton
Mar 19, 2014·JAMA : the Journal of the American Medical Association·Kirsi-Maija KaukonenRinaldo Bellomo
Aug 3, 2014·Chest·Renee D StapletonJ Randall Curtis
Aug 6, 2014·Intensive Care Medicine·Shu-Yu OuYung-Tai Chen
Sep 12, 2014·American Journal of Respiratory and Critical Care Medicine·Pei-wen ChaoYung-Tai Chen

❮ Previous
Next ❯

Citations

Jul 2, 2016·Critical Care : the Official Journal of the Critical Care Forum·H Bryant NguyenEmanuel P Rivers
Sep 3, 2016·American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses·Cindy L Munro, Richard H Savel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved